Coeliac disease is a T-cell-mediated enteropathy induced by gluten. A minority of patients who fail to respond to a gluten-free diet may require intervention with immunomodulating drugs. We report a case of refractory coeliac disease where remission was induced by the anti-tumour necrosis factor-alpha antibody infliximab and was maintained with prednisolone and azathioprine.
|Translated title of the contribution||Refractory coeliac disease: remission with infliximab and immunomodulators|
|Pages (from-to)||667 - 669|
|Number of pages||3|
|Journal||European Journal of Gastroenterology and Hepatology|
|Publication status||Published - Jun 2005|